Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary May 2008 Physician's Accountability for System Failure David Lovinger, MD Dr. Jones has a duty to determine how the test results were lost and why, disclose this information to his patient, Mrs. Taylor, and see that she is not held responsible for the costs of rerunning the test. Virtual Mentor. 2008;10(5):267-270. doi: 10.1001/virtualmentor.2008.10.5.ccas1-0805. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605. Case and Commentary Nov 2023 How Should Organizations and Clinicians Help Marginalized Patients Manage Loneliness as a Harm of Climate Change? Lisa Fuller, PhD Individualistic approaches to the collective problem of climate change are ethically inadequate. AMA J Ethics. 2023;25(11):E802-808. doi: 10.1001/amajethics.2023.802. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary May 2008 Physician's Accountability for System Failure David Lovinger, MD Dr. Jones has a duty to determine how the test results were lost and why, disclose this information to his patient, Mrs. Taylor, and see that she is not held responsible for the costs of rerunning the test. Virtual Mentor. 2008;10(5):267-270. doi: 10.1001/virtualmentor.2008.10.5.ccas1-0805.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605.
Case and Commentary Nov 2023 How Should Organizations and Clinicians Help Marginalized Patients Manage Loneliness as a Harm of Climate Change? Lisa Fuller, PhD Individualistic approaches to the collective problem of climate change are ethically inadequate. AMA J Ethics. 2023;25(11):E802-808. doi: 10.1001/amajethics.2023.802.